231 related articles for article (PubMed ID: 38086100)
1. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review.
Vicente-Zurdo D; Rosales-Conrado N; León-González ME
Talanta; 2024 Mar; 269():125519. PubMed ID: 38086100
[TBL] [Abstract][Full Text] [Related]
2. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol-Selenium Nanoparticles Alleviate Neuroinflammation and Neurotoxicity in a Rat Model of Alzheimer's Disease by Regulating Sirt1/miRNA-134/GSK3β Expression.
Abozaid OAR; Sallam MW; El-Sonbaty S; Aziza S; Emad B; Ahmed ESA
Biol Trace Elem Res; 2022 Dec; 200(12):5104-5114. PubMed ID: 35059981
[TBL] [Abstract][Full Text] [Related]
4. Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota.
Li C; Wang N; Zheng G; Yang L
ACS Appl Mater Interfaces; 2021 Oct; 13(39):46406-46420. PubMed ID: 34569225
[TBL] [Abstract][Full Text] [Related]
5. The effects of polyvinyl alcohol-coated selenium nanoparticles on memory impairment in rats.
Hashemi-Firouzi N; Afshar S; Asl SS; Samzadeh-Kermani A; Gholamigeravand B; Amiri K; Majidi M; Shahidi S
Metab Brain Dis; 2022 Dec; 37(8):3011-3021. PubMed ID: 36271966
[TBL] [Abstract][Full Text] [Related]
6. Selenium Nanoparticles-Enriched
Qiao L; Chen Y; Song X; Dou X; Xu C
Int J Nanomedicine; 2022; 17():4807-4827. PubMed ID: 36246933
[TBL] [Abstract][Full Text] [Related]
7. Anti-amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimer's disease.
Kour A; Tiwari V; Aggarwal N; Sekhar Panda H; Kumar A; Tiwari S; Chauhan VS; Shukla S; Panda JJ
Nanoscale; 2023 Aug; 15(30):12748-12770. PubMed ID: 37477348
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Selenium Nanoparticles with Different Surface Modifications Ameliorate Neuroinflammation through the Gut Microbiota-NLRP3 Inflammasome-Brain Axis in APP/PS1 Mice.
Yang L; Cui Y; Liang H; Li Z; Wang N; Wang Y; Zheng G
ACS Appl Mater Interfaces; 2022 Jul; 14(27):30557-30570. PubMed ID: 35758423
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer's Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation.
Guo X; Lie Q; Liu Y; Jia Z; Gong Y; Yuan X; Liu J
ACS Appl Mater Interfaces; 2021 Jul; 13(26):30261-30273. PubMed ID: 34169710
[TBL] [Abstract][Full Text] [Related]
10. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity, uptake and accumulation of selenium nanoparticles and other selenium species in neuroblastoma cell lines related to Alzheimer's disease by using cytotoxicity assays, TEM and single cell-ICP-MS.
Vicente-Zurdo D; Gómez-Gómez B; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Chim Acta; 2023 Apr; 1249():340949. PubMed ID: 36868776
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties.
Yang L; Wang W; Chen J; Wang N; Zheng G
J Biomed Mater Res A; 2018 Dec; 106(12):3034-3041. PubMed ID: 30295993
[TBL] [Abstract][Full Text] [Related]
13. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
14. Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model.
Mi X; Du H; Guo X; Wu Y; Shen L; Luo Y; Wang D; Su Q; Xiang R; Yue S; Wu S; Gong J; Yang Z; Zhang Y; Tan X
Acta Biomater; 2022 Mar; 141():388-397. PubMed ID: 35045359
[TBL] [Abstract][Full Text] [Related]
15. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway.
Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX
J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922
[TBL] [Abstract][Full Text] [Related]
16. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
17. Dual-functional nanoparticles for precise drug delivery to Alzheimer's disease lesions: Targeting mechanisms, pharmacodynamics and safety.
Zheng X; Zhang C; Guo Q; Wan X; Shao X; Liu Q; Zhang Q
Int J Pharm; 2017 Jun; 525(1):237-248. PubMed ID: 28432017
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer's disease.
Vicente-Zurdo D; Rodríguez-Blázquez S; Gómez-Mejía E; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2022 Nov; 414(26):7573-7584. PubMed ID: 35982253
[TBL] [Abstract][Full Text] [Related]
19. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties.
Nayak V; Patra S; Rout S; Jena AB; Sharma R; Pattanaik KP; Singh J; Pandey SS; Singh RP; Majhi S; Singh KR; Kerry RG
Phytomedicine; 2024 Jan; 122():155150. PubMed ID: 37944239
[TBL] [Abstract][Full Text] [Related]
20. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
